In their elegantly designed work presented by Liu CC et al. [37], the chemoresistance of esophageal cancer stem cells was found to be critically dependent on the activation of HSP27, which implies that Hsp27 could be a novel therapeutic target for treating esophageal cancer. Here, HSPB1 is linked to esophageal cancer.